- New proposals for the future of UK clinical trial legislation
- New Years Honour for Medicines and Healthcare products Regulatory Agency Chief Executive
- Oral COVID-19 antiviral, Paxlovid, approved by UK regulator
- Strong steroid found in ‘natural’ skin cream
- UK regulator approves use of Pfizer/BioNTech vaccine in 5 to 11-year olds
- MHRA's new guidance on using real-world data to support clinical trials could get medicines to patients sooner
- Temporary waiver of 15-minute observation period after COVID-19 mRNA vaccines
- MHRA approves Xevudy (sotrovimab), a COVID-19 treatment found to cut hospitalisation and death by 79%
- Precautionary recall of specific batches of blood pressure drug irbesartan
- MHRA statement on expansion of the COVID-19 vaccination booster programme
- MHRA welcomes today’s announcement by the JCVI
- Life-saving adrenaline auto-injectors could become available in public places
- Labelling error leads to retail-level recall of cold and flu medicine
- First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA
- MHRA’s new Chief Healthcare Quality and Access Officer begins important role
TSET - Technical Specialist Education and Training Group
News and communications from MHRA
By TSETadmin